In contrast to this, the number anti-inflammatory M2-like macrophages, expressing the surface marker CD206 was significantly increased in lipedema patients in the stage-independent analysis (Figure 4B) As before, this analysis was re-assessed by comparing the control subjects to the subgroups representing stages I through III. The gene discussed is MRC1; the disease is Lipedema.